Researchers target 'cell sleep' to lower chances of cancer recurrence and make cancer drugs more effective

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our cancer / oncology section for the latest news on this subject.

The study is a collaboration with the Dana-Farber Cancer Institute in Boston and the Catholic University in Leuven, Belgium.

Additional co-authors of this study include Sergei Boichuk, M.D., Ph.D., Joshua A. Parry, B.S., Kathleen R. Makielski, M.S., Julianne L. Baron, B.S., James P. Zewe, B.S., Keith R. Mehalek, M.S., and Danushka S. Seneviratne, B.S., all of UPCI’s Cancer Virology Program; James A. DeCaprio, M.D., and Larisa Litovchick, Ph.D., both of the Dana-Farber Cancer Institute; Patrick Schöffski, M.D., M.P.H., Maria Debiec-Rychter, M.D., Ph.D., and Agnieszka Wozniak, Ph.D., all of the Catholic University of Leuven in Belgium; and Nina Korzeniewski, Ph.D., of the University of Heidelberg School of Medicine in Germany.

This research was supported by Research Scholar Grant RSG-08-092-01-CCG from the American Cancer Society, the GIST Cancer Research Fund, The Life Raft Group and a number of private donations.

University of Pittsburgh Schools of the Health Sciences

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

University of Pittsburgh Schools of the Health Sci. "Researchers target 'cell sleep' to lower chances of cancer recurrence and make cancer drugs more effective." Medical News Today. MediLexicon, Intl., 5 Aug. 2013. Web.
5 Aug. 2013. APA
University of Pittsburgh Schools of the Health Sci. (2013, August 5). "Researchers target 'cell sleep' to lower chances of cancer recurrence and make cancer drugs more effective." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/264301.php.

Please note: If no author information is provided, the source is cited instead.

View the original article here